The Overuse and Misuse of Antibiotics in Humans and Animals Should Be Prioritized
According to the evidence provided, the research team should prioritize investigating the overuse and misuse of antibiotics in humans and animals as the primary factor driving the global rise of bacterial infections despite medical advancements. This factor is consistently identified across multiple high-quality guidelines as the key driver of antimicrobial resistance (AMR), which is directly responsible for the increasing burden of bacterial infections worldwide 1, 2.
Why Antibiotic Overuse and Misuse Is the Critical Factor
The evidence demonstrates that inappropriate antibiotic use is the well-established key driver of AMR 2. This includes:
- Using antibiotics when none are needed
- Using the wrong antibiotic at the wrong dose
- Incorrect duration of treatment
- Wrong route of administration
This problem affects 30-50% of all antibiotic prescriptions globally 2, making it the most modifiable and impactful factor in the AMR crisis.
The Global Impact
AMR was responsible for 1.27 million direct deaths and contributed to 4.95 million deaths in 2019 2, 3. The WHO declared AMR one of the top 10 global public health threats facing humanity 2. Without intervention, projections estimate 10 million deaths annually by 2050 4.
Why This Factor Takes Priority Over the Other Options
Overuse/Misuse vs. Viral Co-infections
While viral co-infections can complicate bacterial infections, they are not the primary driver of rising bacterial infection rates. In fact, the COVID-19 pandemic demonstrated how viral infections paradoxically increased inappropriate antibiotic use—most hospitalized COVID-19 patients received antibiotics despite SARS-CoV-2 being viral and rarely complicated by bacterial superinfections 2.
Overuse/Misuse vs. Genetic Diversity in Remote Ecosystems
Environmental reservoirs do contribute to resistance gene pools 5, but the evidence clearly shows that human and animal antibiotic consumption drives the selection pressure that amplifies and spreads these resistance mechanisms 1, 6.
Overuse/Misuse vs. Declining Bacterial Pathogenicity
This option contradicts reality—bacterial pathogenicity is not declining. Rather, resistance is making previously treatable infections increasingly difficult to manage, effectively increasing their pathogenic impact on morbidity and mortality.
The One Health Context
The evidence emphasizes that antibiotic overuse spans multiple domains 1, 6:
- Human healthcare: Both hospital and community settings show excessive prescribing
- Animal agriculture: Farmed animals are the leading consumers of antibiotics worldwide, with terrestrial food-animal and aquaculture production driving resistance 7, 5
- Environmental contamination: Poor sanitation and agricultural runoff spread resistant bacteria 1
Supporting Evidence from Global Action Plans
The WHO's 2015 Global Action Plan on AMR specifically identifies "optimize the use of antimicrobial medicines in human and animal health" as objective 4, making antibiotic stewardship a cornerstone of the global response 1, 2. This prioritization is echoed across:
- European and national AMR strategies 1
- The AWaRe classification system developed to guide appropriate antibiotic selection 2
- Low- and middle-income country (LMIC) initiatives where overuse, poor sanitation, and low vaccination rates all contribute to high resistance rates 1
Critical Caveat
While antibiotic overuse is the priority concern, the evidence notes an important paradox: delayed or no access to antibiotics still kills more people than antibiotic-resistant bacteria 1. Therefore, the investigation must balance reducing inappropriate use while ensuring access to effective treatment when necessary—particularly in resource-limited settings.
Practical Research Focus
The investigation should examine:
- Prescribing patterns across healthcare settings (hospital vs. community)
- Agricultural antibiotic use in food production systems
- Surveillance gaps in monitoring resistance and consumption patterns
- Stewardship program effectiveness in reducing inappropriate use
- Access barriers that prevent appropriate antibiotic use when needed
The evidence consistently demonstrates that without addressing antibiotic overuse and misuse through coordinated One Health approaches, the global burden of bacterial infections will continue to rise regardless of other medical advancements 1, 2, 6.